1. Home
  2. VRAX vs HWH Comparison

VRAX vs HWH Comparison

Compare VRAX & HWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • HWH
  • Stock Information
  • Founded
  • VRAX 2013
  • HWH 2021
  • Country
  • VRAX United Kingdom
  • HWH United States
  • Employees
  • VRAX N/A
  • HWH N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • HWH Other Pharmaceuticals
  • Sector
  • VRAX Health Care
  • HWH Health Care
  • Exchange
  • VRAX Nasdaq
  • HWH Nasdaq
  • Market Cap
  • VRAX 17.2M
  • HWH 18.6M
  • IPO Year
  • VRAX 2022
  • HWH N/A
  • Fundamental
  • Price
  • VRAX $1.97
  • HWH $0.72
  • Analyst Decision
  • VRAX
  • HWH
  • Analyst Count
  • VRAX 0
  • HWH 0
  • Target Price
  • VRAX N/A
  • HWH N/A
  • AVG Volume (30 Days)
  • VRAX 4.9M
  • HWH 9.6K
  • Earning Date
  • VRAX 11-26-2024
  • HWH 11-23-2024
  • Dividend Yield
  • VRAX N/A
  • HWH N/A
  • EPS Growth
  • VRAX N/A
  • HWH N/A
  • EPS
  • VRAX N/A
  • HWH N/A
  • Revenue
  • VRAX $156,419.00
  • HWH $1,174,367.00
  • Revenue This Year
  • VRAX $5,169.18
  • HWH N/A
  • Revenue Next Year
  • VRAX $66.97
  • HWH N/A
  • P/E Ratio
  • VRAX N/A
  • HWH N/A
  • Revenue Growth
  • VRAX 1727.11
  • HWH 44.55
  • 52 Week Low
  • VRAX $0.60
  • HWH $0.41
  • 52 Week High
  • VRAX $9.00
  • HWH $12.70
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 46.98
  • HWH 47.06
  • Support Level
  • VRAX $1.92
  • HWH $0.69
  • Resistance Level
  • VRAX $2.50
  • HWH $0.82
  • Average True Range (ATR)
  • VRAX 0.22
  • HWH 0.06
  • MACD
  • VRAX 0.01
  • HWH -0.01
  • Stochastic Oscillator
  • VRAX 26.97
  • HWH 42.86

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About HWH HWH International Inc.

HWH International Inc is a purpose-driven lifestyle company enabling home-based people in the new GIG economy to create lasting wealth. Developing new pathways in the aid of helping people in their pursuit of Health, Wealth and Happiness.

Share on Social Networks: